WelcomeFebruary 24, 2020    

Today's  Poll

Elevated preprocedural CRP is not associated with increased risk for CI-AKI in patients undergoing PCI
True False
Not Sure
Relateed Articles
Sanofi in agreement with Pluromed to buy its U.S. medical device used in surgery

In a statement issued by Sanofi, the French drugmaker announced that it had agreed to buy U.S. medical device company Pluromed to expand its presence in biosurgery.

Sanofi plans to commercialize Pluromed's LeGoo, a gel for temporarily controlling bleeding during surgical procedures.

"LeGoo is a breakthrough technology with the potential to change the paradigm of vascular and cardiovascular surgical procedures, by providing fast, temporary control of blood flow while avoiding vessel trauma associated with standard of care, " said Alison Lawton, senior vice president and general manager at Sanofi Biosurgery. Moreover he added that, "The acquisition of Pluromed underscores Sanofi's commitment to strengthen its biosurgery portfolio."

prescription drug discount cards site coupons for prescriptions
viagra online coupon site discount prescription drug card
prescription card discount site pet prescription discount card
prescription drug coupons charamin.com prescription drug coupons
the cost of abortion areta.se does medicaid cover abortions
abortion methods areta.se arguments for abortion
abortion methods areta.se arguments for abortion
prescription coupon sentencingguidelines.co.uk free prescription drug discount card
free cialis coupon go cialis coupon card
Compiled and edited by the Editorial team and approved by Expert panel of CardioValens.com
Other News
FDA advices not to prescribe Aliskiren drug (Tekturna, Novartis Pharmaceuticals) in combination with ACE inhibitors and angiotensin-receptor blockers for diabetics
Qnexa, the new obesity drug to be reviewed for cardiovascular risks by FDA
ICON's Nuloy, an extremely thin strut coronary stent system gets CE mark approval
Sanofi in agreement with Pluromed to buy its U.S. medical device used in surgery
Now statin labeling to have warnings on risk of diabetes - FDA recommends